Influence of MDR1 genotype on indinavir and saquinavir pharmacokinetics in healthy volunteers.

Trial Profile

Influence of MDR1 genotype on indinavir and saquinavir pharmacokinetics in healthy volunteers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Indinavir (Primary) ; Saquinavir (Primary) ; Midazolam
  • Indications HIV infections
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 04 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Actual patient number (81) added as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top